Dynavax Technologies Corporation
DVAX
$11.25
$0.282.55%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 71.05M | 79.35M | 70.19M | 47.85M | 51.09M |
| Total Other Revenue | 979.00K | 1.29M | 3.61M | 2.95M | 4.51M |
| Total Revenue | 72.03M | 80.63M | 73.80M | 50.79M | 55.60M |
| Cost of Revenue | 31.37M | 26.82M | 26.27M | 23.80M | 21.98M |
| Gross Profit | 40.67M | 53.81M | 47.52M | 26.99M | 33.61M |
| SG&A Expenses | 40.09M | 41.53M | 40.12M | 46.36M | 40.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 71.46M | 68.34M | 66.39M | 70.16M | 62.09M |
| Operating Income | 574.00K | 12.29M | 7.40M | -19.37M | -6.50M |
| Income Before Tax | 7.63M | 19.82M | 14.91M | -11.50M | 996.00K |
| Income Tax Expenses | 579.00K | 2.22M | 3.52M | -2.78M | 777.00K |
| Earnings from Continuing Operations | 7.05M | 17.59M | 11.39M | -8.72M | 219.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.05M | 17.59M | 11.39M | -8.72M | 219.00K |
| EBIT | 574.00K | 12.29M | 7.40M | -19.37M | -6.50M |
| EBITDA | 1.76M | 13.47M | 8.54M | -18.25M | -5.38M |
| EPS Basic | 0.06 | 0.13 | 0.09 | -0.07 | 0.00 |
| Normalized Basic EPS | 0.04 | 0.09 | 0.07 | -0.06 | 0.00 |
| EPS Diluted | 0.04 | 0.12 | 0.08 | -0.07 | 0.00 |
| Normalized Diluted EPS | 0.03 | 0.08 | 0.06 | -0.06 | 0.00 |
| Average Basic Shares Outstanding | 127.95M | 131.13M | 130.92M | 130.20M | 129.38M |
| Average Diluted Shares Outstanding | 153.02M | 154.81M | 154.47M | 130.20M | 133.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
